DEUTSCHE BANK AG\ - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$22,221,000
+74.6%
239,093
+11.9%
0.01%
+66.7%
Q3 2021$12,725,000
-13.2%
213,682
-0.6%
0.01%
-14.3%
Q2 2021$14,661,000
+4.2%
214,971
+6.0%
0.01%
-12.5%
Q1 2021$14,069,000
-11.5%
202,745
-2.0%
0.01%
-20.0%
Q4 2020$15,896,000
+8.0%
206,907
+5.2%
0.01%0.0%
Q3 2020$14,715,000
+15.0%
196,736
-3.2%
0.01%0.0%
Q2 2020$12,798,000
+12.0%
203,307
-25.3%
0.01%0.0%
Q1 2020$11,426,000
+17.4%
272,052
+26.9%
0.01%
+66.7%
Q4 2019$9,735,000
+16.0%
214,377
+16.9%
0.01%0.0%
Q3 2019$8,392,000
-32.7%
183,399
-13.8%
0.01%
-14.3%
Q2 2019$12,471,000
+9.3%
212,741
-16.5%
0.01%0.0%
Q1 2019$11,414,000
+272.2%
254,657
+223.2%
0.01%
+250.0%
Q4 2018$3,067,000
-86.5%
78,785
-84.0%
0.00%
-71.4%
Q3 2018$22,659,000
-8.1%
492,420
-12.9%
0.01%0.0%
Q2 2018$24,648,000
+83.9%
565,381
+66.6%
0.01%
+16.7%
Q1 2018$13,405,000
+113.3%
339,455
+83.4%
0.01%
+50.0%
Q4 2017$6,284,000
+183.1%
185,080
+112.4%
0.00%
+100.0%
Q3 2017$2,220,000
+14.3%
87,146
-24.4%
0.00%
+100.0%
Q2 2017$1,942,000115,2130.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 252,500$11,320,0004.95%
Rubric Capital Management LP 857,103$38,424,0003.59%
PFM Health Sciences, LP 3,255,230$145,932,0003.22%
Partner Investment Management, L.P. 40,605$1,820,0002.10%
DAFNA Capital Management LLC 93,942$4,211,0001.82%
Atika Capital Management LLC 195,000$8,742,0001.78%
Perceptive Advisors 1,400,171$62,770,0001.77%
EMORY UNIVERSITY 47,779$2,142,0001.51%
Rhenman & Partners Asset Management AB 234,558$10,515,0001.23%
Eversept Partners, LP 75,721$3,394,5720.99%
View complete list of ARENA PHARMACEUTICALS INC shareholders